Skip to main content
Moderna, Inc. logo

Moderna, Inc. — Investor Relations & Filings

Ticker · MRNA ISIN · US60770K1079 LEI · 549300EI6OKH5K5Q2G38 US Manufacturing
Open in API
Filings indexed 1,448 across all filing types
Latest filing 2020-01-17 Director's Dealing
Country US United States of America
Listing US MRNA

About Moderna, Inc.

https://www.modernatx.com/

Moderna, Inc. is a biotechnology company pioneering the development of messenger RNA (mRNA) therapeutics and vaccines. The company's core platform utilizes mRNA to carry instructions that direct the body's cells to produce proteins, thereby preventing or treating diseases. This technology enables the rapid design, research, and production of new medicines. Moderna is widely recognized for developing one of the first COVID-19 vaccines. Its research and development pipeline extends to various therapeutic areas, including infectious diseases, immuno-oncology, rare diseases, and autoimmune disorders. The company's mission is to create a new generation of transformative medicines for patients by leveraging the potential of its mRNA platform.

Recent filings

Filing Released Lang Actions
4 Filing
Director's Dealing
2020-01-17 English
4 Filing
Director's Dealing
2020-01-14 English
4 Filing
Director's Dealing
2020-01-14 English
4 Filing
Director's Dealing
2020-01-14 English
4 Filing
Director's Dealing
2020-01-06 English
8-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC by Moderna, Inc. dated January 6, 2020. It reports the issuance of a letter to shareholders regarding the company's cash, cash equivalents, and investments as of December 31, 2019. The document references the letter as Exhibit 99.1, which is attached to the filing. The text explicitly states that the information is not "filed" for purposes of Section 18 and is incorporated by reference only. The document is short (3638 characters) and primarily serves as a current report announcing the letter to shareholders rather than containing detailed financial statements or comprehensive financial data. This fits the profile of a Regulatory Filing (RNS) as it is a current report disclosing information but not a full financial report like an Annual or Interim Report. It is not an earnings release or management discussion, nor is it a proxy or governance document. Therefore, the best classification is Regulatory Filings (RNS).
2020-01-06 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.